Oxygenta Pharmaceutical Limited, a active public limited company, was established on 27 November 1990 in Medak, Telangana, India. Engaging in organic chemicals & compounds within the manufacturing sector, it holds CIN: L24110TG1990PLC012038. Registered under ROC Roc Hyderabad. it is listed on BSE: 524636. It has an authorized capital of ₹37.50 Cr and a paid-up capital of ₹36.98 Cr.
Formerly known as S.S. Organics Pvt Ltd, S.S. Organics Ltd.. It upholds a compliant status. Employing 98 professional, Its leadership includes Vedavathi Gangavaram (Additional Director), Chandra Mouliswar Reddy Gangavaram (Additional Director), Sidda Reddy Kanuparthi (Additional Director). Past directors included Gangi Reddy Narravula, Gowtham Vongumalli Reddy, Muralidhar Rambathri. It holds ₹78.10 Cr open charges and ₹24.20 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Survey No.252/1,Aroor Village,Sadasivapet Mandal, Medak District,, Medak, Telangana.
L24110TG1990PLC012038
012038
27 November 1990
₹37.50 Cr
₹36.98 Cr
Roc Hyderabad
Listed (BSE: 524636)
Active
Explore comprehensive insights into Oxygenta Pharmaceutical Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vedavathi Gangavaram | Additional Director | 20 Jun 2025 | Current |
| Chandra Mouliswar Reddy Gangavaram | Additional Director | 20 Jun 2025 | Current |
| Sidda Reddy Kanuparthi | Additional Director | 20 Jun 2025 | Current |
| Balasubba Reddy Mamilla | Additional Director | 20 Jun 2025 | Current |
| Veera Reddy Arava | Additional Director | 20 Jun 2025 | Current |
| Sharvari Swapnil Shinde | Additional Director | 20 Jun 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 Sep 2023 | Past |
| Pramod Abcsdd | Director | 20 Jun 2017 | Past |
| Pramod Abcsdd | Director | 06 Dec 2021 | Past |
| Pramod Abcsdd | Director | 27 Feb 2017 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Oxygenta Pharmaceutical Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 48.78% decrease. The company also saw a substantial fall in profitability, with a 1795.44% decrease in profit. The company's net worth observed a substantial decline by a decrease of 33.41%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Oxygenta Pharmaceutical had a promoter holding of 8.99% and a public holding of 91.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹781,000,000.00
₹242,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2025 | Others | ₹46.60 Cr | Open |
| 10 Sep 2020 | Others | ₹31.50 Cr | Open |
| 02 Sep 2022 | Others | ₹10.00 Cr | Satisfied |
| 02 Sep 2022 | Others | ₹5.00 Cr | Satisfied |
| 21 Dec 2020 | Others | ₹6.70 Cr | Satisfied |
Explore comprehensive loan charge details -
Oxygenta Pharmaceutical has a workforce of 98 employees as of Sep 11, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Oxygenta Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oxygenta Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Kumkum Bajaj was appointed as a Company Secretary was appointed as a Company Secretary on 12 Sep 2025 & has been associated with this company since 2 months 14 days . was documented.
A charge registered on 02 Sep 2022 via Charge ID 100607750 with Others was fully satisfied on 07 Aug 2025. was recorded as a recent event.
The activity A charge registered on 02 Sep 2022 via Charge ID 100607294 with Others was fully satisfied on 07 Aug 2025. was completed.
The activity A charge with Others amounted to Rs. 46.60 Cr with Charge ID 101130641 was registered on 30 Jun 2025. was completed.
Vedavathi Gangavaram was appointed as a Additional Director was appointed as a Additional Director on 20 Jun 2025 & has been associated with this company since 5 months 6 days . was recorded as a recent event.
Progress on Chandra Mouliswar Reddy Gangavaram was appointed as a Additional Director was appointed as a Additional Director on 20 Jun 2025 & has been associated with this company since 5 months 6 days . was documented.
The CIN of Oxygenta Pharmaceutical Limited is L24110TG1990PLC012038.
Oxygenta Pharmaceutical Limited is headquartered at Survey No.252/1,Aroor Village,Sadasivapet Mandal, Medak District,, Medak, Telangana.
Oxygenta Pharmaceutical Limited was incorporated on 27 November 1990.
The current directors of Oxygenta Pharmaceutical Limited are
The primary industry of Oxygenta Pharmaceutical Limited is Manufacturing.
Oxygenta Pharmaceutical Limited is listed. It is listed on BSE: 524636.
The authorized capital of Oxygenta Pharmaceutical Limited is ₹37.50 Cr, and the paid-up capital is ₹36.98 Cr.
The compliance status of Oxygenta Pharmaceutical Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX